Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Novack

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1987
Plasma levobunolol levels following topical administration with reference to systemic side effectsG D Novack, D D Tang-Liu, E P Kelley, et al.
Journal of Cataract and Refractive Surgery|July 1, 1993
Flurbiprofen 0.03% for the control of inflammation following cataract extraction by phacoemulsificationJ E Blaydes, E P Kelley, J G Walt, et al.
Ophthalmology|November 1, 1993
Vitreous surgery for macular holesR T Wendel, A C Patel, N E Kelly, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 28, 2001
Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjectsM V Mundasad, G D Novack, V E Allgood, et al.
Ophthalmology|February 10, 1999
A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitisD G Shulman, L L Lothringer, J M Rubin, et al.
American Journal of Ophthalmology|October 15, 1987
Glaucoma treatment with once-daily levobunololR David, R J Foerster, M Ober, et al.
The British Journal of Ophthalmology|August 1, 1985
Long-term ocular hypotensive effect of levobunolol: results of a one-year studyM Ober, A Scharrer, R David, et al.
The British Journal of Ophthalmology|April 1, 1987
Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfortG K Krieglstein, G D Novack, E Voepel, et al.
Ophthalmology|March 1, 1992
Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover studyR J Derick, A L Robin, J Tielsch, et al.
American Journal of Ophthalmology|March 15, 1986
Glaucoma treatment with once-daily levobunololT Wandel, A D Charap, R A Lewis, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1987
Plasma levobunolol levels following topical administration with reference to systemic side effectsG D Novack, D D Tang-Liu, E P Kelley, et al.
Journal of Cataract and Refractive Surgery|July 1, 1993
Flurbiprofen 0.03% for the control of inflammation following cataract extraction by phacoemulsificationJ E Blaydes, E P Kelley, J G Walt, et al.
Ophthalmology|November 1, 1993
Vitreous surgery for macular holesR T Wendel, A C Patel, N E Kelly, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 28, 2001
Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjectsM V Mundasad, G D Novack, V E Allgood, et al.
Ophthalmology|February 10, 1999
A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitisD G Shulman, L L Lothringer, J M Rubin, et al.
American Journal of Ophthalmology|October 15, 1987
Glaucoma treatment with once-daily levobunololR David, R J Foerster, M Ober, et al.
The British Journal of Ophthalmology|August 1, 1985
Long-term ocular hypotensive effect of levobunolol: results of a one-year studyM Ober, A Scharrer, R David, et al.
The British Journal of Ophthalmology|April 1, 1987
Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfortG K Krieglstein, G D Novack, E Voepel, et al.
Ophthalmology|March 1, 1992
Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover studyR J Derick, A L Robin, J Tielsch, et al.
American Journal of Ophthalmology|March 15, 1986
Glaucoma treatment with once-daily levobunololT Wandel, A D Charap, R A Lewis, et al.
Pageof 8